Levothyroxine Sample size and study design [Power / Sample Size]

posted by lakshmiprasad – India, 2018-04-14 12:55 (1288 d 16:31 ago) – Posting: # 18681
Views: 3,037

(edited by Ohlbe on 2018-04-16 10:31)

Dear All,

Good Evening,

Here I gone through the all Guidelines, I understood Now because NTI nature (https://www.fda.gov/downloads/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/abbreviatednewdrugapplicationandagenerics/ucm292676.pdf), We are going to do the Fully replicate.

Thank you very much for your guidence.

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Complete thread:

 Admin contact
21,753 posts in 4,548 threads, 1,544 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 05:27 CEST (Europe/Vienna)

They were “so intent of making everything numerical”
that they frequently missed seeing
what was there to be seen.    Barbara McClintock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz